Sanofi to Test Multaq/Ranexa Combo
Sanofi-Aventis, determined to keep Multaq on the market and prove that it is safe and effective to use, has announced that researchers are getting ready to conduct another clinical trial...
Study: Interrupting AF Anticoagulant Treatment Can Double Death Risk
According to a new Danish study, AF patients who currently taking long-term Warfarin are more likely to die or suffer from a thromboembolism within 3 months if that treatment is...
Withholding Clinical Trial Data Should Warrant Penalties, Says Medical Journal
With a significant number of clinical trials getting negative attention these days, a leading medical journal has decided that too much of the data found in them are hidden from...
GregJonesLaw_5Q29_2012-01-30_Mon_No Link Found Between Insulin Resistance, AF
According to a report posted online in the American Journal of Cardiology, a resistance to insulin does not show any major link to atrial fibrillation (AF). This means that insulin...
Study: Imaging May Predict Outcome of Catheter Ablation in AF Patients
According to information from a recent study, the use of imaging may be able to help predict the outcome of atrial fibrillation (AF) patients who choose catheter ablation as a...